nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Ischaemia—Mitoxantrone—lymphatic system cancer	0.0344	0.0344	CcSEcCtD
Pirbuterol—Numbness—Fludarabine—lymphatic system cancer	0.0254	0.0254	CcSEcCtD
Pirbuterol—Sensory loss—Fludarabine—lymphatic system cancer	0.0243	0.0243	CcSEcCtD
Pirbuterol—Numbness—Vincristine—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Pirbuterol—Wheezing—Bleomycin—lymphatic system cancer	0.015	0.015	CcSEcCtD
Pirbuterol—Sensory loss—Vincristine—lymphatic system cancer	0.0149	0.0149	CcSEcCtD
Pirbuterol—Alopecia—Mechlorethamine—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Pirbuterol—Contusion—Mitoxantrone—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Pirbuterol—Stomatitis—Teniposide—lymphatic system cancer	0.0131	0.0131	CcSEcCtD
Pirbuterol—Stomatitis—Fludarabine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Pirbuterol—Flushing—Teniposide—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Pirbuterol—Anorexia—Mechlorethamine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Pirbuterol—Alopecia—Teniposide—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Pirbuterol—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Pirbuterol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Pirbuterol—Agitation—Teniposide—lymphatic system cancer	0.00964	0.00964	CcSEcCtD
Pirbuterol—Alopecia—Fludarabine—lymphatic system cancer	0.00936	0.00936	CcSEcCtD
Pirbuterol—Chest pain—Teniposide—lymphatic system cancer	0.00893	0.00893	CcSEcCtD
Pirbuterol—Confusional state—Teniposide—lymphatic system cancer	0.00863	0.00863	CcSEcCtD
Pirbuterol—Oedema—Teniposide—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Pirbuterol—Agitation—Fludarabine—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Pirbuterol—Stomatitis—Bleomycin—lymphatic system cancer	0.00843	0.00843	CcSEcCtD
Pirbuterol—Tachycardia—Teniposide—lymphatic system cancer	0.00835	0.00835	CcSEcCtD
Pirbuterol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00822	0.00822	CcSEcCtD
Pirbuterol—Anorexia—Teniposide—lymphatic system cancer	0.00816	0.00816	CcSEcCtD
Pirbuterol—Cough—Fludarabine—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Pirbuterol—Hypotension—Teniposide—lymphatic system cancer	0.008	0.008	CcSEcCtD
Pirbuterol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Pirbuterol—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00773	0.00773	CcSEcCtD
Pirbuterol—Confusional state—Fludarabine—lymphatic system cancer	0.00759	0.00759	CcSEcCtD
Pirbuterol—Oedema—Fludarabine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Pirbuterol—Decreased appetite—Teniposide—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Pirbuterol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00738	0.00738	CcSEcCtD
Pirbuterol—Stomatitis—Carmustine—lymphatic system cancer	0.00736	0.00736	CcSEcCtD
Pirbuterol—Rash—Mechlorethamine—lymphatic system cancer	0.00732	0.00732	CcSEcCtD
Pirbuterol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Pirbuterol—Flushing—Bleomycin—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Pirbuterol—Anorexia—Fludarabine—lymphatic system cancer	0.00717	0.00717	CcSEcCtD
Pirbuterol—Weight increased—Mitoxantrone—lymphatic system cancer	0.00716	0.00716	CcSEcCtD
Pirbuterol—Feeling abnormal—Teniposide—lymphatic system cancer	0.00705	0.00705	CcSEcCtD
Pirbuterol—Stomatitis—Vincristine—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Pirbuterol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00702	0.00702	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.007	0.007	CcSEcCtD
Pirbuterol—Nausea—Mechlorethamine—lymphatic system cancer	0.0069	0.0069	CcSEcCtD
Pirbuterol—Alopecia—Bleomycin—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Pirbuterol—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00684	0.00684	CcSEcCtD
Pirbuterol—Glossitis—Methotrexate—lymphatic system cancer	0.00678	0.00678	CcSEcCtD
Pirbuterol—Abdominal pain—Teniposide—lymphatic system cancer	0.00677	0.00677	CcSEcCtD
Pirbuterol—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Pirbuterol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Pirbuterol—Fatigue—Fludarabine—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Pirbuterol—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Pirbuterol—Flushing—Carmustine—lymphatic system cancer	0.00629	0.00629	CcSEcCtD
Pirbuterol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0062	0.0062	CcSEcCtD
Pirbuterol—Asthenia—Teniposide—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Pirbuterol—Pruritus—Teniposide—lymphatic system cancer	0.00606	0.00606	CcSEcCtD
Pirbuterol—Alopecia—Carmustine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Pirbuterol—Cough—Bleomycin—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Pirbuterol—Diarrhoea—Teniposide—lymphatic system cancer	0.00586	0.00586	CcSEcCtD
Pirbuterol—Chest pain—Bleomycin—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Pirbuterol—Alopecia—Vincristine—lymphatic system cancer	0.00572	0.00572	CcSEcCtD
Pirbuterol—Back pain—Carmustine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Pirbuterol—Alopecia—Mitoxantrone—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Pirbuterol—Confusional state—Bleomycin—lymphatic system cancer	0.00556	0.00556	CcSEcCtD
Pirbuterol—Tremor—Carmustine—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Pirbuterol—Oedema—Bleomycin—lymphatic system cancer	0.00552	0.00552	CcSEcCtD
Pirbuterol—Back pain—Vincristine—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Pirbuterol—Vomiting—Teniposide—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Pirbuterol—Agitation—Carmustine—lymphatic system cancer	0.00542	0.00542	CcSEcCtD
Pirbuterol—Asthenia—Fludarabine—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Pirbuterol—Rash—Teniposide—lymphatic system cancer	0.0054	0.0054	CcSEcCtD
Pirbuterol—Dermatitis—Teniposide—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Pirbuterol—Headache—Teniposide—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Pirbuterol—Pruritus—Fludarabine—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Pirbuterol—Back pain—Mitoxantrone—lymphatic system cancer	0.00531	0.00531	CcSEcCtD
Pirbuterol—Anorexia—Bleomycin—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Pirbuterol—Agitation—Vincristine—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Pirbuterol—Hypotension—Bleomycin—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Pirbuterol—Diarrhoea—Fludarabine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Pirbuterol—Nausea—Teniposide—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Pirbuterol—Chest pain—Carmustine—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Pirbuterol—Anxiety—Carmustine—lymphatic system cancer	0.00501	0.00501	CcSEcCtD
Pirbuterol—Confusional state—Carmustine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Pirbuterol—Oedema—Carmustine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Pirbuterol—Decreased appetite—Bleomycin—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Pirbuterol—Cough—Mitoxantrone—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Pirbuterol—Vomiting—Fludarabine—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Pirbuterol—Rash—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Pirbuterol—Dermatitis—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Pirbuterol—Headache—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Pirbuterol—Tachycardia—Carmustine—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Pirbuterol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Pirbuterol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Pirbuterol—Oedema—Vincristine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Pirbuterol—Anorexia—Carmustine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Pirbuterol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Pirbuterol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Pirbuterol—Hypotension—Carmustine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Pirbuterol—Oedema—Mitoxantrone—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Pirbuterol—Nausea—Fludarabine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Pirbuterol—Shock—Mitoxantrone—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Pirbuterol—Anorexia—Vincristine—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Pirbuterol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00437	0.00437	CcSEcCtD
Pirbuterol—Insomnia—Carmustine—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Pirbuterol—Hypotension—Vincristine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Pirbuterol—Somnolence—Carmustine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Pirbuterol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Pirbuterol—Decreased appetite—Carmustine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Pirbuterol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Pirbuterol—Insomnia—Vincristine—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Pirbuterol—Decreased appetite—Vincristine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Pirbuterol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Pirbuterol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Pirbuterol—Fatigue—Vincristine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Pirbuterol—Asthenia—Bleomycin—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Pirbuterol—Pruritus—Bleomycin—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Pirbuterol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Pirbuterol—Fatigue—Mitoxantrone—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Pirbuterol—Abdominal pain—Carmustine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Pirbuterol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00369	0.00369	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Pirbuterol—Abdominal pain—Vincristine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Pirbuterol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Pirbuterol—Vomiting—Bleomycin—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Pirbuterol—Drowsiness—Methotrexate—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Pirbuterol—Rash—Bleomycin—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Pirbuterol—Dermatitis—Bleomycin—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Pirbuterol—Asthenia—Carmustine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Pirbuterol—Stomatitis—Methotrexate—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Pirbuterol—Asthenia—Vincristine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Pirbuterol—Diarrhoea—Carmustine—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Pirbuterol—Nausea—Bleomycin—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Pirbuterol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Pirbuterol—Dizziness—Carmustine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Pirbuterol—Diarrhoea—Vincristine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Pirbuterol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Pirbuterol—Vomiting—Carmustine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Pirbuterol—Dizziness—Vincristine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Pirbuterol—Rash—Carmustine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Pirbuterol—Dermatitis—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Pirbuterol—Headache—Carmustine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Pirbuterol—Vomiting—Vincristine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Pirbuterol—Rash—Vincristine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Pirbuterol—Dermatitis—Vincristine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Pirbuterol—Headache—Vincristine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Pirbuterol—Nausea—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Pirbuterol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Pirbuterol—Rash—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Pirbuterol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Pirbuterol—Headache—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Pirbuterol—Alopecia—Methotrexate—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Pirbuterol—Nausea—Vincristine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Pirbuterol—Nausea—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Pirbuterol—Back pain—Methotrexate—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Pirbuterol—Cough—Methotrexate—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Pirbuterol—Chest pain—Methotrexate—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Pirbuterol—Confusional state—Methotrexate—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Pirbuterol—Anorexia—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Pirbuterol—Hypotension—Methotrexate—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Pirbuterol—Insomnia—Methotrexate—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Pirbuterol—Somnolence—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Pirbuterol—Decreased appetite—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Pirbuterol—Fatigue—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Pirbuterol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Pirbuterol—Abdominal pain—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Pirbuterol—Asthenia—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Pirbuterol—Pruritus—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Pirbuterol—Diarrhoea—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Pirbuterol—Dizziness—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Pirbuterol—Vomiting—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Pirbuterol—Rash—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Pirbuterol—Dermatitis—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Pirbuterol—Headache—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Pirbuterol—Nausea—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
